Arthritis & Rheumatic Diseases

Medicine & Life Sciences

1. Ankylosing Spondylitis 100%
2. Psoriatic Arthritis 41%
3. Rheumatoid Arthritis 40%
4. HIV 36%
5. secukinumab 33%
6. Placebos 32%
7. Tumor Necrosis Factor Inhibitors 31%
8. golimumab 30%
9. India 27%
10. Systemic Lupus Erythematosus 24%
11. T-Lymphocytes 23%
12. Interleukin-17 21%
13. Rheumatology 20%
14. Therapeutics 20%
15. Arthritis 19%
16. Inflammation 19%
17. HIV-1 18%
18. Safety 17%
19. Psoriasis 16%
20. Cytokines 16%
21. Uveitis 15%
22. Microbiota 15%
23. Tumor Necrosis Factor-alpha 15%
24. ixekizumab 15%
25. Joints 14%
26. Gastrointestinal Microbiome 13%
27. Rheumatologists 12%
28. Tuberculosis 11%
29. Blau syndrome 11%
30. Interleukin-1 10%
31. Fibromyalgia 10%
32. Synovial Membrane 10%
33. Anterior Uveitis 10%
34. guselkumab 10%
35. Genes 9%
36. Virus Diseases 9%
37. HIV Infections 9%
38. CD4 Lymphocyte Count 9%
39. Experimental Arthritis 9%
40. Acquired Immunodeficiency Syndrome 9%
41. Baths 8%
42. Inflammatory Bowel Diseases 8%
43. Quality of Life 8%
44. Infections 8%
45. Antirheumatic Agents 8%
46. Cryopyrin-Associated Periodic Syndromes 8%
47. Randomized Controlled Trials 7%
48. Spine 7%
49. Vasculitis 7%
50. Population 7%
51. Signs and Symptoms 7%
52. Serum 7%
53. Interferons 7%
54. Monoclonal Antibodies 6%
55. Systemic Scleroderma 6%
56. Infliximab 6%
57. Spondylitis 6%
58. Biomarkers 6%
59. Opportunistic Infections 6%
60. Chemokines 6%
61. Autoimmune Diseases 6%
62. Interleukin-6 6%
63. Polymerase Chain Reaction 6%
64. HLA-B27 Antigen 6%
65. Patient Reported Outcome Measures 6%
66. Acetylmuramyl-Alanyl-Isoglutamine 6%
67. Back Pain 6%
68. Granulomatosis with Polyangiitis 6%
69. Veterans 5%
70. Rituximab 5%
71. Mycobacterium tuberculosis 5%
72. Peptides 5%
73. Interleukin 1 Receptor Antagonist Protein 5%
74. DNA 5%
75. Nitric Oxide 5%
76. Eye 5%
77. Antibodies 5%
78. Cartilage 5%
79. Sacroiliitis 5%
80. Disease Progression 5%
81. Sacroiliac Joint 5%
82. Blood Cells 5%
83. Reactive Arthritis 5%
84. Hand Bones 5%
85. Lupus Nephritis 5%
86. Antigens 5%
87. Guidelines 5%
88. Lymphocytes 5%